3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Urticaria
1
Sarcoma
1
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Mastocytosis, Systemic
1
Mastocytosis
1
Histiocytoma, Malignant Fibrous
1
Colorectal Neoplasms
1
Angioedemas, Hereditary
1
Angioedema
1
Adenoma, Islet Cell
1
Interventions
lutetium Lu 177 dotatate
4
lanreotide
3
(177)Lu-DOTA-EB-TATE
3
Positron Emission Tomography Computed Tomography
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Metformin
2
Fluorodeoxyglucose F18
2
Everolimus
2
Capecitabine
2
Biopsy
2
177Lu-octreotide, DOTA(0)-Tyr(3)-
2
sintilimab
1
recombinant interferon alpha 2b-like protein
1
gallium Ga 68 dotatate
1
copper dotatate CU-64
1
cabozantinib
1
anlotinib
1
amino-acid, glucose, and electrolyte solution
1
Yttrium-90
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Surgical Procedures, Operative
1
Somatostatin
1
Plastic Surgery Procedures
1
Phlebotomy
1
Nivolumab
1
Needles
1
Magnetic Resonance Spectroscopy
1
Lysine
1
Lutetium-177
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neuroendocrine Tumors
×
Phlebotomy
×
Clear all
NCT03130205
2017-08-25
PROGRESS
Uppsala University
Unknown
30 enrolled